Daflon Uno contre les jambes lourdes, douloureuses et varicosées

The #1 Doctor recommended, non prescription brand for treating chronic venous insufficiency symptoms. 1

Comment fonctionne Daflon ?

wave icon

Les traitements veino-actifs, comme Daflon Uno, sont conçus pour aider à améliorer la santé des veines des jambes en renforçant le tonus de nos veines, qui continuent à s'affaiblir au fur et à mesure que l'insuffisance veineuse chronique progresse.

Daflon Uno a un double mécanisme d'action : son action anti-inflammatoire et veinoprotectrice réduit directement la douleur et le gonflement ; il protège également les capillaires ou les minuscules vaisseaux sanguins afin d'améliorer la microcirculation et le tonus veineux pour une meilleure santé des veines et un soulagement des symptômes tels que la douleur et le gonflement des jambes. 2

S'attaquer aux douleurs des jambes de l'intérieur

wave icon

Daflon Uno est un traitement oral cliniquement prouvé, efficace et pratique, dérivé d'oranges immatures et spécialement formulé pour une absorption maximale 2 .

Cette absorption améliorée signifie que Daflon Uno peut aller à la racine du problème et traiter efficacement les veines de l'intérieur, en améliorant le tonus des veines, en protégeant potentiellement contre la progression de la maladie et en soulageant les symptômes des jambes lourdes et douloureuses. 2

Effet démontré de Daflon Uno après 8 semaines

4 semaines

8 semaines

douleurs aux jambes

50%

63%

sensation de lourdeur

50%

65%

sensation de gonflement

50%

63%

Soulage les symptômes

wave icon

Daflon is the #1 doctor recommended, non prescription brand for treating the symptoms of chronic venous insufficiency. 1

Clinical Studies have shown that Daflon can reduce leg pain and the sensations of heaviness and swelling by up to 50% after only one month of use. These figures were even higher after two months of treatment.

To benefit from your Daflon treatment, you should take your medication as recommended. Be sure to monitor your condition closely and speak with a health care professional if you have any concerns.

Daflon. Naturally sourced, scientifically prepared.

wave icon

L'ingrédient actif de Daflon est une fraction flavonoïque purifiée micronisée (MPFF)6 contenant 90 % de diosmine et 10 % d'autres flavonoïdes exprimés sous forme d'hespéridine.

Les flavonoïdes de Daflon sont extraits d'oranges immatures qui sont riches en ces substances chimiques végétales naturelles. Les composés subissent un processus de purification et de raffinement au cours duquel les particules sont amenées à entrer en collision les unes avec les autres à grande vitesse (micronisation), ce qui les réduit à de minuscules particules, d'une taille inférieure à 2 μm (micronisées). Ces particules plus petites sont absorbées deux fois plus facilement par l'organisme et constituent un ingrédient clé du succès de Daflon en tant que traitement pour améliorer la santé et le tonus des veines dans l'insuffisance veineuse chronique et les hémorroïdes. 6

Informations relatives à la sécurité :

Daflon 500mg Safety Information

Daflon 500: Micronized, purified flavonoid fraction 500 mg: 450 mg diosmin; 50 mg flavonoids expressed as hesperidine.INDICATIONSTreatment of the symptoms of chronic venous disease of the lower limbs, either organic or functional: feeling of heavy legs, pain, night cramps. Treatment of acute hemorrhoidal episodes.DOSAGE AND ADMINISTRATIONIn venous disease: 1000mg daily.In acute hemorrhoidal attacks: the dosage can be increased up to 3000mg daily. CONTRAINDICATIONSHypersensitivity to the active substance or to any of the excipients. WARNINGS The administration of this product for the symptomatic treatment of acute hemorrhoids does not preclude treatment for other anal conditions. If symptoms do not subside promptly, a proctological examination should be performed and the treatment should be reviewed. Excipients: sodium-free.INTERACTION(S) FERTILITY PREGNANCY / LACTATION* Treatment should be avoided. DRIVE & USE MACHINES* UNDESIRABLE EFFECTS* Common: diarrhoea, dyspepsia, nausea, vomiting. Rare: dizziness, headache, malaise, rash, pruritus, urticaria. Uncommon: colitis. Frequency not known: abdominal pain, isolated face, lip, eyelid oedema. Exceptionally Quincke's oedema. OVERDOSE* PROPERTIES* Vascular protector and venotonic. [Tradename] acts on the return vascular system: it reduces venous distensibility and venous stasis; in the microcirculation, it normalizes capillary permeability and reinforces capillary resistance. PRESENTATION* LES LABORATOIRES SERVIER, 50 rue Carnot, 92284 Suresnes cedex France. www.servier.com * For complete information, please refer to the Summary of Product Characteristics for your country.

Mentions légales Daflon 1000mg

Daflon 1000: Micronized, purified flavonoid fraction 1000 mg: 900 mg diosmin; 100 mg flavonoids expressed as hesperidine. INDICATIONSTreatment of the symptoms of chronic venous disease of the lower limbs, either organic or functional: feeling of heavy legs, pain, night cramps. Treatment of acute hemorrhoidal episodes.DOSAGE AND ADMINISTRATIONIn venous disease: 1000mg daily.In acute hemorrhoidal attacks: the dosage can be increased up to 3000mg daily. CONTRAINDICATIONSHypersensitivity to the active substance or to any of the excipients. WARNINGS The administration of this product for the symptomatic treatment of acute hemorrhoids does not preclude treatment for other anal conditions. If symptoms do not subside promptly, a proctological examination should be performed and the treatment should be reviewed. Excipients: sodium-free.INTERACTION(S) FERTILITY PREGNANCY / LACTATION* Treatment should be avoided. DRIVE & USE MACHINES* UNDESIRABLE EFFECTS* Common: diarrhoea, dyspepsia, nausea, vomiting. Rare: dizziness, headache, malaise, rash, pruritus, urticaria. Uncommon: colitis. Frequency not known: abdominal pain, isolated face, lip, eyelid oedema. Exceptionally Quincke's oedema. OVERDOSE* PROPERTIES* Vascular protector and venotonic. [Tradename] acts on the return vascular system: it reduces venous distensibility and venous stasis; in the microcirculation, it normalizes capillary permeability and reinforces capillary resistance. PRESENTATION* LES LABORATOIRES SERVIER, 50 rue Carnot, 92284 Suresnes cedex France. www.servier.com * For complete information, please refer to the Summary of Product Characteristics for your country.

Références:

1. IQVIA Daflon sales data MAT Q2 2021 2. Adapted from Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181-254.1 3. Garner RC, Garner JV, Gregory S, Whattam M, Calam A, Leong D. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci. 2002;91:32-40. 4. Gilly R, Pillion G, Frileux C. Evaluation of a new venoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology. 1994;9:67-70. 5. Pascarella L, Lulic D, Penn AH, et al. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Eur J Vasc Endovasc Surg. 2008;35(1):102-110. 6. Summary of Product Characteristics Daflon

2025